Efficacy and safety of corticosteroids in critically ill patients: a systematic review and meta-analysis
Description
When someone is critically ill, whether battling sepsis, ARDS, or severe pneumonia, corticosteroids have long been a debated topic. A massive new meta-analysis pooling data from over 10,000 ICU patients finally brings clarity. The headline: early, low-dose, prolonged steroid therapy cuts short-term mortality by roughly 15%, slashes ICU stays by 2 days, reduces time on ventilators by over 4 days, and boosts ventilator-free days—all without increasing infection or bleeding risks. Sure, there’s a slight uptick in hyperglycemia, but that’s a small price for improved survival and recovery
What does this mean for frontline clinicians? Think “early, gentle, and sustained.” Start steroids within the first 72 hours, keep them on for at least a week, and tailor doses to lower than 400 mg of hydrocortisone per day. Most surprisingly, even septic shock patients benefit most when hydrocortisone is paired with fludrocortisone
Want to see the full picture? Check out the study: “Efficacy and safety of corticosteroids in critically ill patients” by Lei Cao et al. in BMC Anesthesiology (July 2025).
United States
